First Quadrant’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-13,821
| Closed | -$1.33M | – | 347 |
|
|
2021
Q4 | $1.33M | Hold |
13,821
| – | – | 0.14% | 136 |
|
|
2021
Q3 | $1.2M | Hold |
13,821
| – | – | 0.14% | 140 |
|
|
2021
Q2 | $1.13M | Hold |
13,821
| – | – | 0.13% | 149 |
|
|
2021
Q1 | $1.31M | Hold |
13,821
| – | – | 0.14% | 142 |
|
|
2020
Q4 | $857K | Buy |
13,821
+6,617
| +92% | +$410K | 0.09% | 176 |
|
|
2020
Q3 | $428K | Sell |
7,204
-1,912
| -21% | -$114K | 0.05% | 237 |
|
|
2020
Q2 | $636K | Buy |
+9,116
| New | +$636K | 0.09% | 219 |
|
|
2019
Q2 | – | Sell |
-3,238
| Closed | -$254K | – | 733 |
|
|
2019
Q1 | $254K | Sell |
3,238
-4,841
| -60% | -$380K | 0.02% | 460 |
|
|
2018
Q4 | $684K | Sell |
8,079
-1,693
| -17% | -$143K | 0.06% | 300 |
|
|
2018
Q3 | $1.67M | Buy |
9,772
+6,503
| +199% | +$1.11M | 0.04% | 331 |
|
|
2018
Q2 | $422K | Buy |
+3,269
| New | +$422K | 0.01% | 513 |
|
|
2014
Q4 | – | Sell |
-23,724
| Closed | -$695K | – | 795 |
|
|
2014
Q3 | $695K | Hold |
23,724
| – | – | 0.02% | 414 |
|
|
2014
Q2 | $922K | Buy |
23,724
+16,190
| +215% | +$629K | 0.02% | 397 |
|
|
2014
Q1 | $316K | Buy |
7,534
+1,603
| +27% | +$67.2K | 0.01% | 487 |
|
|
2013
Q4 | $195K | Buy |
+5,931
| New | +$195K | ﹤0.01% | 560 |
|